• AAPL 169.89
  • TSLA 170.18
  • AMZN 173.67
  • MSFT 399.04
  • INTC 35.11
  • EURUSD 1.0738
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TO /
  3. BCT.TO

Briacell Therapeutics Corp (BCT TO) stock market data APIs

C$3.33 0.32(10.6%) as of April 25, 2024

Briacell Therapeutics Corp Financial Data Overview

2.51
3.33
-
2.91
2.86
2.8-10.1982
48 105 K
15 982 K
0
-0.71
1.754
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BCT',
Type: 'Common Stock',
Name: 'Briacell Therapeutics Corp',
Exchange: 'TO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
ISIN: 'CA10778Y3023',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'July',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Briacell Therapeutics Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -31 699 992
  • Earnings Per Share -1.08
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Briacell Therapeutics Corp Earnings via APIs

  • Latest Release 2024-03-18
  • EPS/Forecast -0.2

Get Briacell Therapeutics Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Briacell Therapeutics Corp latest news via APIs

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

After only 3 cycles, patient experienced a remarkable improvement of eye-bulging “proptosis” caused by orbital metastatic breast cancer tumor behind the eye. Significant ocular pain reduction reco...
  • BRIACELL THERAPEUTICS CORP
  • HEALTH
  • TORONTO STOCK EXCHANGE:BCT

BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND

BriaCell demonstrates unprecedented broad immune system activation in tumor models by BriaCell’s next generation breast and prostate cancer immunotherapies Data supports further development of BriaC...
  • BRIACELL THERAPEUTICS CORP
  • CALENDAR OF EVENTS
  • TORONTO STOCK EXCHANGE:BCT
Do you have any questions?
support@eodhistoricaldata.com